{
  "schema_version": "1.0",
  "id": "https://review.menopausecalculator.com/veozah-vs-lynkuet/#answer",
  "canonical_url": "https://review.menopausecalculator.com/veozah-vs-lynkuet/",
  "question": "Veozah vs Lynkuet: monitoring and prescription differences",
  "answer": "Veozah (fezolinetant) and Lynkuet (elinzanetant) are different nonhormonal medicines for menopausal hot flashes. Their liver-testing schedules and safety considerations differ. Comparing their labels can clarify the practical choice, but these sources do not establish a head-to-head efficacy winner.",
  "entity_ids": [
    "veozah",
    "lynkuet"
  ],
  "sources": [
    {
      "url": "https://www.astellas.com/us/system/files/veozah_uspi.pdf",
      "locator": "Highlights; sections 1, 2 and 5",
      "checked": "2026-09-15"
    },
    {
      "url": "https://labeling.bayerhealthcare.com/html/products/pi/Lynkuet_PI.pdf",
      "locator": "August 2026 label; sections 1, 2 and 5",
      "checked": "2026-09-15"
    }
  ],
  "editorial_decision_notes": "Take two separate pharmacy quotes to the discussion and request a lab-cost estimate for each proposed plan. A tablet count is not a capsule count: ask the pharmacy to state days supplied. Record whether laboratory fees are billed through medical coverage and prescription fees through pharmacy coverage. A low advertised refill price cannot establish the combined cost. If the clinician rules one option out, remove it from the financial comparison rather than keeping it as a misleading cheaper alternative.",
  "questions": [
    {
      "question": "Does nonhormonal mean no monitoring?",
      "answer": "No. Both labels include liver assessment. Use each product\u2019s own schedule rather than applying one schedule to the other."
    },
    {
      "question": "Can I compare trial percentages as a ranking?",
      "answer": "This guide does not make that ranking. Separate trials can differ in participants, endpoints and follow-up."
    },
    {
      "question": "What should my insurer quote?",
      "answer": "The exact product, strength, quantity and days supplied, plus any authorization requirement."
    },
    {
      "question": "Is the newer product automatically a better fit?",
      "answer": "Approval date alone does not settle suitability. Ask how the warnings, other medicines and daily routine apply to you."
    }
  ],
  "scope": "US; discussion preparation, not prescribing",
  "price": null,
  "stock": "not_verified",
  "clinical_review": "not_performed",
  "indexation_decision": "KEEP",
  "meta_description": "Compare Veozah and Lynkuet routines, liver monitoring and access questions. Review sourced differences before discussing treatment.",
  "decision_details": {
    "title": "What changes in the day-to-day treatment plan?",
    "headers": [
      "Decision point",
      "Veozah",
      "Lynkuet"
    ],
    "rows": [
      [
        "Labeled routine",
        "45 mg once daily.",
        "120 mg as two 60 mg capsules at bedtime; interacting medicines can require a different plan."
      ],
      [
        "Liver bloodwork",
        "Before treatment, monthly during the first three months, then at months 6 and 9.",
        "Before treatment and at month 3; additional assessment may be needed."
      ],
      [
        "A difference to raise at the visit",
        "The label has a boxed warning for liver injury and contraindicates CYP1A2 inhibitors.",
        "The label warns about daytime impairment and CNS effects; discuss driving and other sedating medicines."
      ],
      [
        "What to put in the budget",
        "The prescribed tablet supply plus the ordered laboratory work.",
        "The prescribed capsule supply plus the ordered laboratory work."
      ]
    ],
    "note": "These are selected label distinctions, not a complete safety screen or an efficacy ranking. Symptoms or abnormal results can change monitoring. Ask the prescriber to review the full medicine list before either option enters a price comparison.",
    "sources": [
      "https://www.astellas.com/us/system/files/veozah_uspi.pdf",
      "https://labeling.bayerhealthcare.com/html/products/pi/Lynkuet_PI.pdf"
    ],
    "checked": "2026-09-16"
  },
  "editorial_updated": "2026-09-16",
  "commercial_update_checked": "2026-09-17",
  "commercial_update": "Access and savings: two programs, not a $5 price contest  The manufacturers advertise conditional commercial minimums of $30 for Veozah refills and $25 for Lynkuet. Those headlines have different program rules and do not establish a matched personal price. Veozah also advertises an eligible first-fill offer; Lynkuet lists a separate BlinkRx route.  Astellas: Veozah savings and eligibility .  Bayer: Lynkuet cost and savings .  Veozah\u2019s label calls for baseline liver tests, monthly checks for the first three months, and checks at months six and nine. Lynkuet\u2019s label calls for baseline and three-month liver testing and includes daytime-impairment warnings. Price the actual clinician-ordered care rather than assuming identical monitoring expenses.  Veozah prescribing information .  Lynkuet prescribing information .  Use  Veozah\u2019s cost guide  and  Lynkuet\u2019s combined cost and savings guide  for dated restrictions. Government-insurance patients should use the plan and appropriate assistance routes, not assume the commercial cards apply.",
  "indexation": "index,follow",
  "commercial_sources": [
    {
      "url": "https://www.veozah.com/savings",
      "title": "Astellas: Veozah savings and eligibility",
      "type": "primary_program",
      "checked": "2026-09-17"
    },
    {
      "url": "https://www.lynkuet-us.com/cost-savings",
      "title": "Bayer: Lynkuet cost and savings",
      "type": "primary_program",
      "checked": "2026-09-17"
    },
    {
      "url": "https://www.astellas.com/us/system/files/veozah_uspi.pdf",
      "title": "Veozah prescribing information",
      "type": "primary_label",
      "checked": "2026-09-17"
    },
    {
      "url": "https://labeling.bayerhealthcare.com/html/products/pi/Lynkuet_PI.pdf",
      "title": "Lynkuet prescribing information",
      "type": "primary_label",
      "checked": "2026-09-17"
    }
  ]
}